INJ PRICE ANALYSIS
Injective (INJ) Holds Above $13 as Bulls Eye $15.71 Resistance Target
INJ trades at $13.92 (+0.58% daily) with strong bullish momentum intact following recent 14% surge and technical breakout above key resistance levels.
Injective (INJ) Maintains Bullish Momentum Near $15 After 14% Surge
INJ trades at $14.83 with strong bullish signals as technical breakout and strategic partnerships drive sustained momentum toward $15.71 resistance level.
Injective (INJ) Breaks $15 Resistance as Bulls Target $15.48 on EVM Testnet Momentum
INJ surges to $15.19 (+6.75%) breaking multi-week downtrend with RSI at 72.96 showing overbought conditions as EVM testnet launch and strategic partnerships fuel bullish momentum.
Injective (INJ) Surges 14% Above Resistance as Bulls Target $15.48 - Technical Breakout Analysis
Injective breaks multi-week downtrend with strong momentum, trading at $14.23 after key resistance breakouts. Technical indicators signal continued bullish momentum.
Injective (INJ) Surges 15% on EVM Testnet Launch and Strategic Partnerships: Technical Analysis & Price Outlook
Injective rallies 15% following EVM testnet launch and partnerships with Google Cloud and Deutsche Telekom. Technical indicators suggest continued bullish momentum.
Injective (INJ) Surges on EVM Testnet Launch Amid Bullish Momentum: Price Outlook and Key Insights
Injective (INJ) sees a 15% surge following the EVM testnet launch and bullish technical breakout. With a teased announcement on July 17, market sentiment remains high.
Injective (INJ) Gains Momentum: EVM Testnet, Partnerships, and Bullish Price Trends
Injective (INJ) surges with its EVM testnet launch, partnerships with Google Cloud and Deutsche Telekom, and a potential 3x rally. Here's what traders need to know.
Injective (INJ): EVM Testnet Launch, Strategic Partnerships, and Bullish Momentum in 2025
Injective (INJ) gains momentum with its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and bullish price action above $13.50.
Injective (INJ) Gains Momentum with EVM Testnet, Institutional ETF Filing, and Strategic Partnerships
Injective (INJ) pushes forward with bullish developments, including an EVM testnet launch, institutional ETF filing, and regulatory collaboration, signaling long-term growth prospects.
Injective (INJ) Rallies 15%: EVM Testnet Launch and Strategic Partnerships Drive Growth
Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and growing DeFi adoption.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout
Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+.